Formulation and Efficacy of Exercise Prescription for Patients With Coronary Heart Disease
NCT ID: NCT04923711
Last Updated: 2021-06-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2021-06-01
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise Adherence in Home-based Cardiac Rehabilitation
NCT04970979
Exercise Adherence of Home-based Cardiac Rehabilitation
NCT04961606
Study on Exercise Safety of Patients With Cardiovascular Diseases
NCT04963478
Effect of Individualized Exercise in Elderly Patients With Coronary Heart Disease
NCT06588231
Study of Rehabilitation Therapy on Patients After Acute Myocardial Infarction
NCT00725088
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Moderate Intensity Group
Group received a moderate exercise prescription of moderate intensity
Moderate intensity exercise prescription
Exercise Intensity： Low-risk patients: the lower of 60-69% reserve heart rate or the heart rate at the anaerobic threshold.
Moderate-risk or high-risk patients: the lower of 50-59% reserve heart rate or the heart rate at the anaerobic threshold.
High Intensity Group
Group received a moderate exercise prescription of high intensity
High intensity exercise prescription
Exercise Intensity： Low-risk patients: the lower of 70-85% reserve heart rate or the heart rate at the anaerobic threshold.
Moderate-risk or high-risk patients: the lower of 60-70% reserve heart rate or the heart rate at the anaerobic threshold.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Moderate intensity exercise prescription
Exercise Intensity： Low-risk patients: the lower of 60-69% reserve heart rate or the heart rate at the anaerobic threshold.
Moderate-risk or high-risk patients: the lower of 50-59% reserve heart rate or the heart rate at the anaerobic threshold.
High intensity exercise prescription
Exercise Intensity： Low-risk patients: the lower of 70-85% reserve heart rate or the heart rate at the anaerobic threshold.
Moderate-risk or high-risk patients: the lower of 60-70% reserve heart rate or the heart rate at the anaerobic threshold.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Uncontrolled tachycardia (heart rate at rest \>120bpm
* Uncontrolled polypnea（breath rate at rest \>30 breath per minute
* Uncontrolled respiratory failure （SPO2 ≤90%）
* Uncontrolled hyperglycemia (Random blood glucose\>18mmol/L)
* Uncontrolled malignant arrhythmia with hemodynamic instability
* Uncontrolled septic shock and septicopyemia
* Uncooperation of the patients
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jing Ma
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jing Ma
Clincial professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jing Ma
Role: PRINCIPAL_INVESTIGATOR
Department of Cardiology in Chinese PLA General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chinese PLA General Hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jing Ma
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-249
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.